Smartleaf Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$187K Buy
3,019
+678
+29% +$47.2K 0.01% 810
2025
Q4
$157K Buy
2,341
+366
+19% +$23.7K 0.01% 932
2025
Q3
$131K Buy
1,975
+988
+100% +$78.2K 0.01% 926
2025
Q2
$85.2K Sell
987
-410
-29% -$32.1K 0.01% 923
2025
Q1
$94.6K Buy
1,397
+109
+8% +$8.89K 0.01% 857
2024
Q4
$100K Buy
1,288
+108
+9% +$8K 0.01% 843
2024
Q3
$79.4K Buy
1,180
+530
+82% +$43.5K 0.01% 779
2024
Q2
$74.5K Buy
650
+295
+83% +$37.3K 0.01% 646
2024
Q1
$49.5K Buy
355
+172
+94% +$21.6K 0.01% 676
2023
Q4
$22.7K Buy
+183
New +$18.7K 0.01% 653

Other funds holding DXCM

Smartleaf Asset Management's DXCM Position: Q1 2026 in Review

Smartleaf Asset Management increased its DexCom (DXCM) stake by 29% in Q1 2026, buying an estimated $47.2K and bringing the position to 3,019 shares worth $187K. The position accounts for 0.01% of the portfolio, ranked #810.

Smartleaf Asset Management first reported a position in DXCM in Q4 2023 and has held it in 10 quarters since. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Smartleaf Asset Management held 3,019 shares of DexCom worth $187K as of Q1 2026.
  • Smartleaf Asset Management bought 678 DexCom shares in Q1 2026, an estimated $47.2K.
  • DexCom made up 0.01% of Smartleaf Asset Management's portfolio in Q1 2026, its #810 holding.
  • Smartleaf Asset Management first reported a position in DexCom in Q4 2023 and has held it in 10 quarters since.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.